Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT04999293
Eligibility Criteria:
Inclusion Criteria:
* Ageā„75 years old;
* Treated with PCI (limited to stent implantation) ;
* Survivors and treated with DAPT (aspirin \[100 mg once daily\], cilostazol, or indobufen)combined with a P2Y12 receptor antagonist \[clopidogrel (75 mg once daily) or ticagrelor (90 mg twice daily)\]) at discharge;
Exclusion Criteria:
* Coronary artery bypass graft (CABG) or only drug conservative treatment during hospitalization;
* Concurrent use of oral anticoagulants;
* Inability to tolerate long-term antiplatelet therapy, such as active bleeding and a bleeding tendency;
* Acute infectious diseases;
* Cognitive impairment;
* Declined re-examination.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
75 Years
Study:
NCT04999293
Study Brief:
Protocol Section:
NCT04999293